Frost & Sullivan Recognizes Corista with its 2014 North America New Product Innovation Award

The award acknowledges Corista’s significant advances in enabling pathologists to manage workflows comprehensively and time-efficiently, regardless of location or hardware (scanner and device).

For the past several years, Frost and Sullivan has been proactively looking at the digital pathology market and marketplace among hardware and software manufacturers as well as looking at trends, adoption and market size in different countries. The award announced last week recognizes Corista for New Product Innovation in its image-centric platform for real-time workflow and collaboration.

The award is a worthy achievement for Corista – and a source of some pride for me as well. For the past few years, I have used the DP3 platform in a large urban healthcare setting with centralized technical services and decentralized professional services across multiple states. In that setting I provided insights that helped shape the product to meet the needs of pathologists. In that environment – a typical one for many healthcare systems, I experienced the difference in providing care with a wide array of scanners and image formats in the ever changing pathology and digital pathology marketplace. My work with the company led to me becoming Corista’s Chief Medical Officer earlier this year.

I encourage you to read the full report (Frost & Sullivan 2014 Corista Award) for Frost and Sullivan’s approach to product research and trends they see emerging in the digital pathology market. Some of their key analysis shows:

“As anatomic pathology increases in importance, accessibility to digitized images also becomes more important. The workload in many laboratories is estimated to increase by about 8% to 10% each year, and Frost & Sullivan has noticed that more clinical laboratories are purchasing digital pathology systems to meet this demand; vendors are also pushing high throughput scanners in an attempt to address the growing workload. It is estimated that most laboratories during a forecast period of 7 years will switch to digital pathology and there are scanners in the market that have increased their capacity to scan about 200,000 slides annually when operated 24/7. However, digitizing the workflow solves only one of the issues, and many challenges associated with interconnectivity, remote patient monitoring, and collaborative work still prevail.

Frost & Sullivan sees Telepathology as the future of pathology, allowing physicians to search through vast image repositories to identify anomalies across various patients, organs, and tissues. Frost & Sullivan is convinced that, in the near future, there will be a tremendous need for solutions that offer content-based image analytics, on top of the demand for whole slide imaging (WSI) scanners and image analysis solutions.”

DP3 enables real-time remote expert diagnosis, enabling pathologists to manage workflows comprehensively and time-efficiently

Based on its recent analysis of the image-centric workflow platforms market, Frost & Sullivan recognizes Corista with the 2014 North America Frost & Sullivan Award for New Product Innovation. Corista’s DP3 platform significantly improves image management for digital pathology by being a unified system, connecting scanners of all makes and models to pathologists within an organization and across the world.

Using the hardware-agnostic DP3, a pathologist or a physician can access slide images and offer diagnosis from any location on any browser-enabled device, including mobile tablets. This device enables smaller, remote facilities that are unable to afford expensive scanners to have their digital images read by external experts.

“The DP3 not only offers browser-based access from any connected device, but also aids the gathering of structured data through its customer-configurable synoptic reporting,” said Frost & Sullivan Senior Industry Analyst Divyaa Ravishankar. “Its image-centric approach is also user-centric, with clean, intuitive interfaces that improve its ease of use and adoptability. DP-3’s synchronized viewing and collaboration capabilities, allows a pathologist to collaborate on cases in both real-time, or within their regular workflows.”

Additionally, the platform’s integrated support for use in tumor boards brings diagnostic imaging to the forefront in support of cross-department decision-making and peer review. Hospitals can achieve a substantial improvement in their pathological workflow and, eventually, better patient outcomes because of its incredible ability to significantly improve image management for digital pathology and telepathology.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.